Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion type Assertion NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_head.
- NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion description "[Most were overexpressed in ovarian cancer compared with ovarian surface epithelium and/or inclusion cysts (EpCAM, EZH2, BIRC5) although BIRC5 and EZH2 were expressed as highly in fallopian tube epithelium as in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_provenance.
- NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion evidence source_evidence_literature NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_provenance.
- NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion SIO_000772 21423607 NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_provenance.
- NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion wasDerivedFrom befree-2016 NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_provenance.
- NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_assertion wasGeneratedBy ECO_0000203 NP881202.RAFJ6KHBXJrzzBv6ZUpOkqAq5TwKc9njQal3D6ZkZ3iBg130_provenance.